首页|nSIMV配合肺泡表面活性物质对呼吸窘迫综合征早产儿血气指标及临床疗效的影响

nSIMV配合肺泡表面活性物质对呼吸窘迫综合征早产儿血气指标及临床疗效的影响

扫码查看
目的 探讨鼻塞式同步间歇指令通气(nSIMV)与肺泡表面活性物质对呼吸窘迫综合征早产儿的影响。方法 80例呼吸窘迫综合征早产儿,根据治疗方案不同分为观察组(40例)和对照组(40例)。对照组行nSIMV治疗,观察组在对照组基础上加用肺泡表面活性物质注射用牛肺表面活性剂。比较两组临床疗效、血气指标[动脉血氧分压(PaO2)、动脉血二氧化碳分压(PaCO2)]、呼吸相关指标[吸入氧浓度(FiO2)、吸气峰压(PIP)、平均气道压(MAP)]。结果 观察组治疗总有效率95。00% 高于对照组的80。00%,差异有统计学意义(P<0。05)。治疗24 h,两组PaO2、PaCO2均有改善,且观察组PaO2(72。45±7。74)mm Hg(1 mm Hg=0。133 kPa)高于对照组的(62。90±6。64)mm Hg,PaCO2(45。08±5。41)mm Hg低于对照组的(50。84±5。56)mm Hg,差异有统计学意义(P<0。05)。治疗12 h,两组FiO2、PIP、MAP均有改善,且观察组FiO2(0。34±0。11)、PIP(20。22±1。89)cm H2O(1 cm H2O=0。098 kPa)、MAP(10。21±0。98)cm H2O均低于对照组的(0。47±0。15)、(22。23±2。43)cm H2O、(11。29±1。24)cm H2O,差异有统计学意义(P<0。05)。结论 nSIMV配合肺泡表面活性物质,可改善呼吸窘迫综合征早产儿血气分析和呼吸相关指标,提高临床疗效。
Effect of nSIMV combined with alveolar surfactant on blood gas indexes and clinical efficacy of premature infants with respiratory distress syndromea
Objective To explore the effect of nasal synchronized intermittent mandatory ventilation (nSIMV) combined with alveolar surfactant on blood gas indexes and clinical efficacy of premature infants with respiratory distress syndrome. Methods According to different treatment regimens,80 premature infants with respiratory distress syndrome were divided into an observation group (40 cases) and a control group (40 cases). The control group was treated with nSIMV,and the observation group was treated with alveolar surfactant of calf pulmonary surfactant for injection based on the control group. Both groups were compared in terms of clinical efficacy,blood gas indexes[arterial partial pressure of oxygen (PaO2),arterial partial pressure of carbon dioxide (PaCO2)]and respiratory related indexes[fractional inspired oxygen concentration (FiO2),peak inspiratory pressure (PIP),mean airway pressure (MAP)]. Results The total effective rate of 95.00% in the observation group was higher than 80.00% in the control group,and the difference was statistically significant (P<0.05). After 24 h of treatment,PaO2 and PaCO2 were improved in both groups;the observation group had higher PaO2 of (72.45±7.74) mm Hg (1 mm Hg=0.133 kPa) than (62.90±6.64) mm Hg in the control group,and lower PaCO2 of (45.08±5.41) mm Hg than (50.84±5.56) mm Hg in the control group;the difference was statistically significant (P<0.05). After 12 h of treatment,FiO2,PIP and MAP were improved in both groups;the observation group had FiO2 of (0.34±0.11),PIP of (20.22±1.89) cm H2O (1 cm H2O=0.098 kPa) and MAP of (10.21±0.98) cm H2O,which were lower than (0.47±0.15),(22.23±2.43) cm H2O and (11.29±1.24) cm H2O in the control group;the difference was statistically significant (P<0.05). Conclusion The combination of nSIMV and alveolar surfactant can improve the blood gas analysis and respiratory related indexes of premature infants with respiratory distress syndrome,and effectively improve clinical efficacy.

Premature infantsRespiratory distress syndromeNasal synchronized intermittent mandatory ventilationAlveolar surfactantBlood gas indexes

吴国豪、张卓辉、潘嘉浩

展开 >

524500 吴川市妇幼保健计划生育服务中心新生儿科

早产儿 呼吸窘迫综合征 鼻塞式同步间歇指令通气 肺泡表面活性物质 血气分析

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(23)